Intractable chronic lymphocytic leukemia and interferon.
The hypothesis that interferon may be useful for intractable chronic lymphocytic leukemia (CLL) is based on two incidental findings: first, the similarity in the in vitro radioresistance of the blood lymphocytes of intractable CLL and of hairy cells; secondly, the similarity of the incidence of intractable CLL patients and the incidence of CLL patients who respond to interferon treatment.
Schrek
R
R
Research Service, VA Hospital, Hines, IL.
D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008954:Models, Biological
D007372:Interferons